Feature | May 15, 2012| Dave Fornell

A Cardiac Picture Is Worth a Thousand Words

As an editor for DAIC and Imaging Technology News, I am a third-party observer in the cardiac and radiology markets. I also am a  patient who recently received medical imaging. With both these sets of experience, I am of the opinion that physicians often miss an opportunity to connect with their patients in a critical way, one which could increase patient involvement and compliance for treatments and follow-up exams.  

I believe there is a disconnect due to the large knowledge void that separates them. Clinicians frequently need to translate diagnostic findings into layman’s terms so their patients understand, but much is often lost in translation. To bridge this gap, I believe medical imaging holds the key, because a picture is worth a thousand words. If you show a patient a picture of something that is normal and another image of the same thing that is abnormal, patients get it, even if they can’t identify the anatomy. 

I made some interesting observations after a software vendor granted me an account for its cloud-based advanced visualization software. I used it to open and manipulate DICOM CT and MRI datasets given to me on CDs by family and co-workers, creating an archive of generic medical images for use in DAIC. Interestingly, after I showed the patients their images, they were surprised to see their ailments visualized for the first time.  In most cases, their doctors never showed or explained the images. 

The most striking instance was with my mom, who gave me her CT angiography that was performed more than a year ago. Her doctor told her she had some atherosclerosis and should change her diet and exercise more. She did what many patients do — ignored the warning because she felt fine. While the radiology report noted a calcified ostial stenosis in the right coronary artery and a few small calcified aortic lesions, she never saw any actual pictures from the exam, and reading the written report was meaningless to her.  A few days after I showed her images of the lesions, on her own she scheduled a follow-up doctor visit for additional tests and modified her diet. 

Seeing apparently is believing (or at least scaring patients to action) when it comes to clogged arteries. In a clinical study highlighted at the American College of Cardiology (ACC) meeting in March, 2,100 patients were shown CT images of their clogged arteries to measure compliance to diet, exercise and statin use. Research showed individuals with the most severe disease who saw images of their heart were 2.5 times more likely to take statins as directed and more than three times more likely to lose weight compared to those who had a scan and saw little or no evidence of underlying disease. 

I believe making medical images, especially anatomical 3-D reconstructions, more accessible to patients has the potential to change patient treatment and prevention compliance. It also might offer a business point-of-difference in a healthcare market that is increasingly consumer-driven.

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems | December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems | October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems | October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems | August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems | July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems | May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems | May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems | February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems | January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems | November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init